Page 38 - E Ltd News Today

Antibodies develop 2 weeks after second dose Covid vaccination to be voluntary, confirms health ministry Six candidates undergoing clinical trials in India at the moment Getting vaccinated for Covid-19 will be voluntary, the Union Health Ministry has said while underlining that the vaccine introduced in India will be as effective as any vaccine dev...

4-MIN READ Getting Vaccinated for Covid-19 Will be Voluntary, Says Health Ministry Vials with a sticker reading, COVID-19/Coronavirus vaccine/Injection only, and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020. (Image: Reuters/Dado Ruvic) Six vaccines are undergoing clinical trials in India. The government is geared to launch a vaccine for COVID-19 soon, it said. FOLLOW US ON: New Delhi: Getting vaccinated for COVID-19 will be vol...

Covid-19 vaccination in India will be voluntary, says health ministry Representational image. Star Online Report Star Online Report Getting the Covid-19 vaccine will be on a voluntary basis, Indian Health Ministry said as the country prepares to launch a drive to administer the vaccines possibly by next month. The ministry said it was advisable to receive a complete schedule of the coronavirus vaccine irrespective of past history of infection with Cov...

Updated Dec 18, 2020 | 14:24 IST The ministry said registration of a beneficiary is mandatory for vaccination for COVID-19. Only after registration the information on the session site to visit and time will be shared. Representational image&nbsp | &nbspPhoto Credit:&nbspPTI New Delhi: Getting vaccinated for COVID-19 will be voluntary, the Union Health Ministry has said while underlining that the vaccine introduced in India will be as effective as any vaccine developed by ...

OPPI brings high voltage discussion on healthcare transformation OPPI brings high voltage discussion on healthcare transformation 17 December 2020 | News The two-day summit began with an address by Sharad Tyagi, President, OPPI on ‘Reimagining India’s Healthcare in the next decade’ Source credit: Shutterstock DV Sadananda Gowda, Minister for Chemicals and Fertilisers, launched the 9th edition of  Organisation of Pharmaceutical Producers of India (OPPI)’s Annual Summit - Heal...

Last Updated: BBLs Covaxins Phase-1 Trials Interim Findings Indicate Vaccine well-tolerated Interim findings from phase-1 trials of BBLs Covaxin was well-tolerated in all dose groups with no serious adverse events, as it awaits DGCIs emergency nod As both Serum Institute of India (SII) and Bharat Biotech Ltd (BBL) await the Drug Controller of India (DGCI)s approval of emergency use of their Coronavirus (COVID-19) vaccines, interim findings from phase-1 trials of BBLs Covaxin was well-toler...

DCGI seeking more data for authorisation wont impact COVID-19 vaccine roll-out timeline: Govt The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said PTI | December 16, 2020 | Updated 08:32 IST Six vaccines are undergoing clinical trials in India. The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use au...

In the Phase 1 study, which is being jointed conducted by the ICMR, the researchers have said the reactogenicity “was absent in the majority of participants, with mild events”. And on immune response, the researchers concluded that both “robust humoral and cell-mediated responses were observed”. “…this study has several strengths. To ensure generalizability, this study was conducted with participants from diverse geographic locations and socioeconomic conditions, enrolling 375 parti...

Covaxin: No serious adverse events found, Bharat Biotech Phase 1 result shows A medic administers Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, during the Phase- 3 trials at the Peoples Medical College in Bhopal (PTI)Premium Share Via Read Full Story Indias first indigenous Covid-19 vaccine Covaxin, developed by Bharat Biotech in association with Indian Council of Medical research, was found to be "well tolerated in all dose groups with no v...

URL copied REPRESENTATIONAL IMAGE The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug regulator DCGI seeking more data from these companies will not impact the vaccine-roll out timeline. These applications filed with the Drugs Controller General of India are being examined by the subject expert committee on COVID-19 of CDSCO for emergency use au...